Pharmacological actions of N-(2-o-methoxyphenoxyethyl)-6,7-dimethoxy-3,4-dihydro-2-(1H)-isoquinoline carboxamidine hydrobromide (SC-3123).
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000578:Amidines / Q000494:pharmacology*; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects; D002415:Cats; D004285:Dogs; D005725:Ganglia, Autonomic / Q000187:drug effects; D007001:Hypogastric Plexus / Q000187:drug effects; D007082:Ileum / Q000187:drug effects; D007546:Isoquinolines / Q000494:pharmacology*; D008297:Male; D008738:Methyl Ethers / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D009541:Nictitating Membrane / Q000187:drug effects; D051381:Rats; D014649:Vas Deferens / Q000187:drug effects
D000317:Adrenergic alpha-Antagonists; D000578:Amidines; D000959:Antihypertensive Agents; D007546:Isoquinolines; D008738:Methyl Ethers